Ocular Photo-Bio-Stimulation Optics for Peripheral Retina Coverage

Resolve Bottlenecks,
Find Innovative Solutions
Generate Solutions

Solution Overview

Problem

Existing ocular photo-bio-stimulation technologies fail to effectively stimulate a significant portion of the retina, particularly the mid and far peripheral regions, and do not adequately balance light intensity, wavelength, and color transmission to optimize dopamine production and ensure safe driving conditions.

Innovation Solution

Sunglass lenses and optics that deliver targeted light stimulation to the entire retina, including peripheral regions, balancing light intensity, wavelength, and color transmission to enhance dopamine production while ensuring compliance with ISO and ANSI traffic light tests.

Engineering Contradictions & Design Principles

VSEngineering Contradiction Analysis

1Area of stationary object

If existing ocular photo-bio-stimulation technologies are used, then some retinal stimulation is achieved, but the mid and far peripheral regions of the retina are not effectively stimulated

Engineering Contradiction:
Improveretinal stimulation coverageVSAvoidstimulation effectiveness
Core Design Contradiction:
Area of stationary objectVSReliability

Solution Approach 1:

The optical system divides the retinal stimulation into multiple zones: a central zone for foveal stimulation and peripheral zones for mid and far peripheral retinal stimulation. This segmentation allows targeted light delivery to different retinal regions that were previously underserved by conventional single-zone approaches.

Inventive Principle:
Principle #1Segmentation

Solution Approach 2:

The patent introduces peripheral visual field stimulation as a new dimension beyond traditional central vision correction. By incorporating peripheral zones in the optical design, the system extends stimulation from the traditional two-dimensional central macular region to include the three-dimensional peripheral retinal architecture.

Inventive Principle:
Principle #17Another dimension (Dimensionality change)

2Quantity of substance

If light intensity is increased to enhance dopamine production, then dopamine production is improved, but safe driving conditions may be compromised

Engineering Contradiction:
Improvedopamine productionVSAvoiddriving safety
Core Design Contradiction:
Quantity of substanceVSObject-affected harmful factors

Solution Approach 1:

The optical system applies different light intensity characteristics to different zones: the central zone provides appropriate illumination for driving safety, while peripheral zones deliver optimized light intensity for dopamine production. This local differentiation allows simultaneous achievement of safety and therapeutic effects without compromise.

Inventive Principle:
Principle #3Local quality

Solution Approach 2:

The system dynamically adjusts light parameters including intensity, wavelength, and duration across different retinal zones. By varying these parameters locally, the system maximizes dopamine production in peripheral regions while maintaining safe visibility levels in the central driving zone.

Inventive Principle:
Principle #35Parameter changes

3Reliability

If wavelength selection is optimized for dopamine production, then therapeutic effect is improved, but color transmission for safe driving may be affected

Engineering Contradiction:
Improvetherapeutic effectVSAvoidcolor transmission
Core Design Contradiction:
ReliabilityVSIllumination intensity

Solution Approach 1:

Different wavelength selections are applied to different retinal zones: peripheral zones utilize wavelengths optimized for dopamine production, while the central zone transmits colors appropriate for safe driving. This local spectral differentiation resolves the contradiction between therapeutic optimization and driving safety.

Inventive Principle:
Principle #3Local quality

Solution Approach 2:

The optical system segments the spectral transmission into different zones, allowing each zone to receive wavelength-optimized light for its specific function. This segmentation enables simultaneous optimization of both therapeutic effects and driving safety through wavelength selection.

Inventive Principle:
Principle #1Segmentation

Applied Scientific Principles

This section explains which scientific principles are used to turn an abstract innovation direction into a practical engineering solution.

Function Achieved in This Case

Enhances dopamine production and provides clear vision by stimulating the entire retina with optimized light intensity and color balance, ensuring safe driving conditions.

Implementation Method 1

light wavelengths that strike the eye's retina which fall within the wavelength range of at least one of: 480 nm+/−30 nm, 490 nm+/−5 nm, 490 nm+/−10 nm, 490 nm+/−20 nm, 490 nm+/−30 nm, 495 nm+/−5 nm, 495 nm+/−10 nm, 495 nm+/−20 nm, 495 nm+/−30 nm, 500 nm+/−5 nm, 500 nm+/−10 nm, 500 nm+/−20 nm, 500 nm+/−30 nm

Methodology Applied
Scientific EffectPhoto-stimulation of photoreceptors: Photoelectric Effect

Implementation Method 2

The light transmission within the range of 450 nm to 510 nm will stimulate/activate the melanopsin and/or the rhodopsin in the ipRGC and rods photoreceptors, respectively

Methodology Applied
Scientific EffectMelanopsin absorption: Absorption (EM radiation)

Implementation Method 3

a filtered lens or filtered optic, or sunglass lens or sunglass optic, that transmits light within the wavelength range of 450 nm to 510 nm

Methodology Applied
Scientific EffectOptical filtering: Filter (optical)

Data Source

PatentUS20250295935A1Identification and Prevention of Myopia
Publication Date: 2025.09.25 NEURORAYS LLC
  • US20250295935A1 patent drawing
  • US20250295935A1 patent drawing
  • US20250295935A1 patent drawing

AI summary

A system for providing ocular photo-bio-stimulation to an eye of a subject.